To determine the abundance of immune cells in the tumor, we used the function cytomappershiny from the package cytomapper of R. We selected neutrophils, CD4+ and CD8+ T-lymphocytes and myeloid cells (except neutrophils) manually based on the expression of specific markers (Fig. 2a). This evidence concerns the gene CD8A and neoplasm.